Machine learning-based prediction of intensive care unit admission in COVID-19 patients presenting with mild respiratory failure

基于机器学习的COVID-19轻度呼吸衰竭患者入住重症监护室预测

阅读:1

Abstract

INTRODUCTION: Previous studies applying machine learning to predict severe respiratory failure in COVID-19 patients have shown inconsistent results due to variations in study populations and predictor variables. This study aimed to predict intensive care unit admission and identify key predictive factors. METHODS: This retrospective cohort study included patients with COVID-19 who presented with mild respiratory failure, most of whom received oxygen via a mask or nasal cannula. Eight machine learning algorithms-XGBoost, support vector machines, neural networks, k-nearest neighbors, random forest, decision trees, logistic regression, and naïve Bayes-were applied to predict intensive care unit admission. RESULTS: A total of 392 patients (63.5% male, mean age, 55.0 ± 15.3 years) were included in the study. During follow-up, 80 patients (20.4%) required intensive care unit admission. Among them, 320 (81.6%) received steroid therapy, 301 (76.8%) underwent pulse steroid therapy, and 76 (19%) had been vaccinated. The multilayer perceptron, XGBoost, and radial basis function support vector machine models achieved the best overall performance based on ROC-AUC and accuracy values (ROC-AUC: 0.75, 0.70, and 0.71; accuracy: 0.79, 0.79, and 0.79, respectively). The strongest predictors of intensive care unit admission were low lymphocyte count on the first day, as well as high age, ferritin, body mass index, Charlson Comorbidity Index, and computed tomography score. CONCLUSION: Machine learning algorithms can reliably predict intensive care unit admission in COVID-19 patients with mild respiratory failure. These models identified key clinical and laboratory factors that may facilitate early risk stratification and guide treatment planning.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。